Demars Financial Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,636
Closed -$224K 71
2022
Q2
$224K Sell
6,636
-1,811
-21% -$63.4K 0.13% 73
2022
Q1
$295K Sell
8,447
-10
-0.1% -$342 0.15% 72
2021
Q4
$258K Buy
8,457
+1,396
+20% +$45.5K 0.14% 77
2021
Q3
$232K Sell
7,061
-2,772
-28% -$88.7K 0.14% 80
2021
Q2
$298K Buy
+9,833
New +$324K 0.18% 74

Other funds holding OGN

Demars Financial Group's OGN Position: Q3 2022 in Review

Demars Financial Group sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 6,636 shares — an estimated $224K sold.

Demars Financial Group first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $298K in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Demars Financial Group reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Demars Financial Group sold 6,636 Organon & Co shares in Q3 2022, an estimated $224K.
  • Demars Financial Group first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Demars Financial Group's Organon & Co position peaked at $298K in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Demars Financial Group's 13F filing for Q3 2022, filed 21 Oct 2022.